Reviews
Experimental models of Sjögren's syndrome: differences and similarities with human disease
A. Kaklamanos1, A.V. Goules2, A.G. Tzioufas3
- Department of Pathophysiology, Medical School, National and Kapodistrian University of Athens, Greece.
- Department of Pathophysiology, Medical School, National and Kapodistrian University of Athens, Greece.
- Department of Pathophysiology, Medical School, National and Kapodistrian University of Athens, Greece. agtzi@med.uoa.gr
CER15916
2022 Vol.40, N°12
PI 2398, PF 2412
Reviews
Free to view
(click on article PDF icon to read the article)
PMID: 36305363 [PubMed]
Received: 03/06/2022
Accepted : 11/07/2022
In Press: 19/10/2022
Published: 20/12/2022
Abstract
Mouse models have been employed extensively to provide pathogenetic insights into many complex human disorders including systemic autoimmune diseases. The explosion of biotechnology and molecular biology have simplified the procedures to design and generate mouse models with the phenotype of interest. In this line, more than 30 mouse models have been proposed or developed to resemble Sjögren’s syndrome (SS) in humans, in an attempt to better understand the pathophysiology of the disease and design more effective treatments. So far, none of these models has been proven an ideal recapitulation of the human disease, although each model mimics particular aspects of the human SS counterpart. This review summarises the main characteristics of the mouse models of SS that have been developed hitherto, comparing them with the human SS in terms of clinical features, sex predilection, histopathology, autoantibodies production, and propensity for lymphoma. The interpretation of these experimental models with cautiousness and the realisation of the differences between human and mouse physiology and disease pathophysiology, may render mice a useful tool to study in depth SS and reveal new therapeutic perspectives.
